New combo therapy aims to halt rapid heart disease progression in inflamed arteries
NCT ID NCT05860400
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a comprehensive treatment plan can reduce heart attacks and other serious events in people with rapidly-progressive coronary artery disease tied to inflammation. Researchers will compare each participant's outcomes before and after treatment. The study enrolls 39 adults who have already had heart procedures like stents or bypass surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking Union Medical College Hospital
RECRUITINGBeijing, Beijing Municipality, 100730, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan replace invasive heart imaging before bypass surgery?
- Epilepsy drug may protect organs during heart surgery — trial tests the idea
- A simple eye mask might protect sleep and calm confusion after heart surgery
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program